Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve
article
OA: bronze
CC0
⤵ 174 in-corpus citations
AI-generated summary
Both endometrioma presence and surgical excision significantly decreased ovarian reserve as measured by serum AMH levels, with the decline sustained six months post-surgery.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: Do the presence of endometriomas and their laparoscopic excision lead to a decrease in ovarian reserve as assessed by serum anti-Müllerian hormone (AMH) levels? SUMMARY ANSWER: Both the presence and excision of endometriomas cause a significant decrease in serum AMH levels, which is sustained 6 months after surgery. WHAT IS KNOWN ALREADY: No previous comparison of serum AMH levels between women with and without endometrioma has been reported. However, studies have suggested a decline in serum AMH levels 1-3 months after endometrioma excision but long-term data are needed. STUDY DESIGN, SIZE, DURATION: A prospective cohort study including 30 women with endometrioma >2 cm were age matched with 30 healthy women without ovarian cysts. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with endometrioma underwent laparoscopic excision with the stripping technique. Serum AMH level and antral follicle count (AFC) were determined preoperatively, 1 and 6 months after surgery. Correlation analyses were undertaken in order to identify determinants of surgery-related change in ovarian reserve. MAIN RESULTS AND THE ROLE OF CHANCE: Compared with controls at baseline, women with endometrioma had lower AMH levels (4.2 ± 2.3 versus 2.8 ± 2.2 ng/ml, respectively, P = 0.02) and AFC (14.7 ± 4.1 versus 9.7 ± 4.8, respectively, P < 0.01). Serum AMH levels were further decreased 6 months after surgery (2.8 ± 2.2 versus 1.8 ± 1.3 ng/ml, P = 0.02), while AFC remained unchanged (9.7 ± 4.8 versus 10.4 ± 4.2, P = 0.63). The rate of decline in AMH was not correlated with age, laterality of endometrioma, cyst diameter or the number of primordial follicles on the surgical specimens. The preoperative serum AMH level was positively correlated with the rate of decline in serum AMH after surgery (r = 0.47, P = 0.02). LIMITATIONS, REASONS FOR CAUTION: The absence of a non-treated group of women with endometriomas as a further control prevents comment on the presence of a progressive decline in ovarian reserve related to endometrioma per se. The sample size may be too small for detection of factors correlated with the extent of ovarian damage. WIDER IMPLICATIONS OF THE FINDINGS: While the findings are mostly in agreement with previous studies, the present study is the first to show that the presence of endometrioma per se is associated with a decrease in ovarian reserve. The extent of surgery-related decline in ovarian reserve is not predictable using preoperative or perioperative factors. It may be prudent to measure AMH levels preoperatively and delay/avoid surgical excision as far as is possible if subsequent fertility is a concern. Additional studies are required to further investigate whether the endometrioma-related decline in ovarian reserve per se is progressive in nature and whether it exceeds the surgery-related decline. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the Research Fund of the Uludag University School of Medicine. The authors have no conflict of interest associated with this study.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Can symptomatology help in the diagnosis of endometriosis? Findings from a national case–control study—Part 1 via openalex
- Effects of laparoscopic surgery on serum anti-müllerian hormone levels in reproductive-aged women with endometrioma via openalex
- Effects of ovarian endometrioma on the number of oocytes retrieved for in vitro fertilization via openalex
- Endometrioma ≤3 cm in Diameter per se Does Not Affect Ovarian Reserve in Intracytoplasmic Sperm Injection Cycles via openalex
- Endometriosis: pathogenetic implications of the anatomic distribution. via openalex
- Epidemiology of endometriosis in a Norwegian county via openalex
- Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels via openalex
- Management of endometrioma prior to IVF: compliance with ESHRE guidelines via openalex
- National survey of the current management of endometriomas in women undergoing assisted reproductive treatment via openalex
- Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease via openalex
- Pelvic Endometriosis Diagnosed in an Entire Nation Over 20 Years via openalex
- Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany via openalex
- Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications via openalex
- The Impact of Excision of Ovarian Endometrioma on Ovarian Reserve: A Systematic Review and Meta-Analysis via openalex
- The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study via openalex
- The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis via openalex
- The presence of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins via openalex
- W2045341652 via openalex
- W2167400693 via openalex
- W2063086232 via openalex
- W2011872290 via openalex
- W2010247448 via openalex
- W1999996730 via openalex
- W2129766185 via openalex
- W1983885518 via openalex
Cited by (50)
- Prognostic determinants for clinical pregnancy rate following IVF in women with ovarian endometriomas? A propensity score-matched retrospective cohort study 2026
- Impact of oral contraceptive treatment duration on ovarian reserve markers and pain in women with ovarian endometrioma: a retrospective cohort study 2026
- Women with endometriosis who undergo IVF: a contemporary review of therapeutic strategies for successful outcomes 2025
- The influence of ovarian cyst type and size on ovarian reserve markers: implications for fertility counseling and preservation strategy 2025
- Endometriosis Surgery: Debates About Restorative Reproductive Medicine 2025
- Evidence on Serum Anti-Müllerian Hormone Levels and Endometriosis Surgery 2025
- Women with endometriosis who undergo IVF: a contemporary review of therapeutic strategies for successful outcomes 2025
- Impact of non-medical treatments of endometrioma on pregnancy outcome: a systematic review and meta-analysis 2025
- The Effect of Surgery on Endometriomas on Fertility (2025 Second Edition): Scientific Impact Paper No 55 2025
- Endometrioma and Infertility 2025
- Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023 2024
- Risk factors associated with changes in serum anti-Müllerian hormone levels before and after laparoscopic cystectomy for endometrioma 2024
- Enhanced peroperative imaging of endometriosis and peritoneal carcinomatosis 2024
- The impact of surgical treatment of benign ovarian tumors on the reproductive health of women, taking into account the International Classification of Functioning 2024
- Apoptotic Pathways and Anti-Müllerian Hormone affects the Ovarian Tissue Damage during Endometrioma Cystectomy 2024
- Impact of Laparoscopic Ovarian Cystectomy on Ovarian Reserve Assessed by Serum Anti-Mullerian Hormone in Benign Ovarian Cysts: A Prospective Observational Study 2024
- Surgical Treatment of Endometriomas: Impact on Ovarian Reserve 2024
- Impact of Endometrioma Surgery on Fertility: A Prospective Cohort Study (Preprint) 2024
- Ethanol Sclerotherapy in the Management of Ovarian Endometrioma: Technical Considerations for Catheter- and Needle-Directed Sclerotherapy 2024
- Impact of Surgery for Ovarian Endometriomas on the Outcomes of In Vitro Fertilization 2024
- Outpatient diagnosis and drug therapy of endometriosis: A review 2024
- Assessment of Ovarian Reserve in Women with Endometriosis 2024
- Endometrioma surgery: Hit with your best shot (But know when to stop) 2024
- Analysis of factors affecting pregnancy rate after laparoscopic surgery for infertility associated with endometriosis 2024
- Chapter 11. Endometriosis-related complications in women undergoing in-vitro fertilization 2024
- Expectant, Medical, and Surgical Management of Ovarian Endometriomas 2023
- Is AMH Prediction of Menopause? 2023
- The Impact of Endometrioma on Embryo Quality in In Vitro Fertilization: A Retrospective Cohort Study 2023
- Impact of Ovarian Endometrioma and Surgery on Reproductive Outcomes: A Single-Center Spanish Cohort Study 2023
- Impact of ovarian diseases on fertility reserve as assessed through serum AMH levels in reproductive age women 2023
- Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes 2023
- Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes 2023
- Fertility Preservation in Women with Endometriosis 2023
- Characteristics of patients with stage III and IV ovarian endometriomas and trends in postoperative anti-Mullerian hormone changes 2023
- Clinical Analysis of Anti-Mullerian Hormone Levels in Serum of Patients with Ovarian En-dometriosis Cysts 2023
- Impacts of endometrioma on ovarian aging from basic science to clinical management 2023
- Use of Oxidized Regenerated Cellulose (ORC) in treatment of ovarian endometriomas to prevent recurrence and preserve ovarian reserve 2023
- Endometriosis in Reproductive Years: Fertility 2022
- CO2 fiber laser vaporization for endometrioma treatment results in preserved ovarian responsiveness and improved embryo quality in infertile women undergoing ART 2022
- Overexpression of ErbB-1 (EGFR) Protein in Eutopic Endometrium of Infertile Women with Severe Ovarian Endometriosis during the ‘Implantation Window’ of Menstrual Cycle 2022
- Risk Factors for Anti Mullerian Hormone Decline after Laparoscopic Excision of Endometrioma: A Prospective Study 2022
- Long-Term Follow-Up Of Anti-Mullerian Hormone Levels After Laparoscopic Endometrioma Cystectomy 2022
- Combined effects of age and endometriosis on ovarian reserve in women with infertility 2022
- Identification of lesional attributes of dysmenorrhea severity and the serum antimüllerian hormone levels in women with ovarian endometriomas 2022
- Effect of surgical treatment on fertility in patients with endometrioid cysts 2022
- Overexpression of ErbB-1 (EGFR) Protein in Eutopic Endome-Trium of Infertile Women with Severe Ovarian Endometriosis during the ‘Implantation Window’ of Menstrual Cycle 2022
- The Impact of Endometriosis on Controlled Ovarian Stimulation Outcome 2022
- Presence of Endometrioma Does Not Impair Embryo Quality and Assisted Reproductive Technology (ART) Cycle Outcome in Diminished Ovarian Reserve (DOR) Patients 2022
- Association of Endometrioma Size with Serum Anti-mullerian Hormone 2022
- A Real-world Study of Changes in Preoperative and Postoperative CA125, A and M H in Patients with Endometriosis 2022
Source provenance
- europepmc
- last seen: 2026-06-23T06:15:44.889181+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:19:05.543671+00:00
License: CC0
· commercial use OK